Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.

Journal of Public Health in Africa (ISSN: 2038-9922, E-ISSN: 2038-9930) is a premier open-access journal published by PAGEPRESS PUBL, dedicated to advancing the field of public health within the African context. Established in 2010, this journal provides a platform for researchers, practitioners, and policymakers to disseminate original research, reviews, and case studies that contribute to the understanding of public health challenges and advancements in Africa. With its increasing visibility, the journal is positioned in the Q4 quartile in the categories of Public Health, Environmental and Occupational Health and currently ranks #474 out of 577 in its field according to Scopus metrics. The open access model ensures that vital research is freely accessible to a global audience, thus enhancing knowledge sharing and collaboration. Since coverage of the journal has been discontinued in Scopus after previous years, authors are encouraged to contribute innovative findings which address pressing health issues, ultimately striving to improve health outcomes across the continent. The journal is based in Italy and invites submissions from diverse disciplines to promote a multidisciplinary approach to public health.

Lancet Regional Health-Americas is a premier open-access journal published by ELSEVIER, dedicated to advancing knowledge in the fields of health policy, internal medicine, and public health within the Americas. Established in 2021, this journal has quickly risen to prominence, achieving Q1 status in renowned categories such as Health Policy, Internal Medicine, and Public Health, Environmental and Occupational Health as of 2023. With impressive rankings, including a placement of #25 out of 310 in Health Policy and #68 out of 665 in Public Health, this journal exemplifies a commitment to impactful research and dissemination of critical health knowledge. The journal is accessible to a broad audience and promotes open scientific dialogue and exchange of innovative solutions to regional health challenges. Researchers, professionals, and students alike will find Lancet Regional Health-Americas a vital resource for the latest developments and discussions shaping the health landscape in the Americas.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Journal of Global Infectious Diseases, published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the field of infectious diseases, offering insightful research and critical analyses that contribute to global health discourse. Since its inception as an Open Access journal in 2009, it has aimed to disseminate knowledge on various facets of infectious diseases, fostering collaboration among researchers, clinicians, and public health professionals. With an impact factor indicative of its growing significance—ranked in the Q3 category of Infectious Diseases for 2023—this journal publishes a diverse range of studies, from basic science to clinical applications. Its dedicated contributions help address pressing health challenges and enhance knowledge sharing in an era where infectious diseases pose significant threats worldwide. Based in India, the journal not only highlights regional health issues but also connects to the broader global landscape, making it an essential platform for anyone interested in advancing the field.

One Health is a premier open-access journal published by Elsevier, dedicated to advancing the interconnected disciplines of Infectious Diseases and Public Health. Established in 2015, the journal aims to promote holistic approaches to health that consider the interactions between humans, animals, and the environment. With an impressive impact factor and recognition in the top quartiles of both Infectious Diseases and Public Health categories, One Health ranks highly within the Scopus database, showcasing its significant contribution to the field. Situated in the Netherlands, the journal encourages scholarly communication and collaboration, providing a vital platform for researchers, professionals, and students to disseminate their findings and strengthen global health initiatives. By utilizing the open access model, One Health ensures that critical research is freely available, fostering a broader understanding of health-related issues that span multiple sectors.

The Central European Journal of Public Health, ISSN 1210-7778 and E-ISSN 1803-1048, is a vital academic forum published by the NATIONAL INSTITUTE OF PUBLIC HEALTH, Czech Republic. With its comprehensive coverage of contemporary issues in public health and medicine since its inception in 1993, this journal aims to bridge the gap between research and practice, fostering a deeper understanding of health dynamics within Central Europe and beyond. As a Q3 ranked journal in both the fields of Medicine (miscellaneous) and Public Health, Environmental and Occupational Health as per 2023 metrics, it provides an accessible platform for innovative studies, policy analyses, and reviews that contribute to the global discourse on public health challenges. Though primarily based in the Czech Republic, it welcomes contributions from a worldwide audience, enhancing its scope and impact. Researchers, practitioners, and students will find invaluable insights that not only enrich academic scholarship but also inform effective public health interventions.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.